Mifepristone Makers File Emergency Appeal to Supreme Court to Block In-Person Pickup Rule
The manufacturers of mifepristone, a key abortion pill, have launched an emergency appeal to the Supreme Court seeking to immediately pause a ruling from the 5th US Circuit Court of Appeals that reinstates nationwide in-person dispensing requirements for the medication.
The rushed appeal, filed with conservative Justice Samuel Alito, aims to halt the lower court’s decision that experts warn will cause confusion and severely restrict access to one of the most common methods of abortion care—especially critical following the Supreme Court’s 2022 overturn of Roe v. Wade.
Danco Laboratories, the drug’s primary manufacturer, told the justices in the appeal filed Saturday that the 5th Circuit’s ruling “injects immediate confusion and upheaval into highly time-sensitive medical decisions.” The company raised urgent questions about patients with appointments this weekend or those attempting to fill prescriptions prescribed remotely in states like New York, Minnesota, Washington, and others.
“What should a patient do if she cannot obtain an in-person appointment immediately?” Danco’s attorneys wrote.
The company urged the Supreme Court to grant an “administrative stay” that would suspend the 5th Circuit’s decision while the Court considers the merits of the case. The fast-track appeal puts the issue of abortion medication back before the nation’s highest court less than two years after a similar challenge was struck down— a decision that enabled the drug to remain broadly accessible via telehealth services.
Background: Telehealth Access Faces New Legal Hurdles
Since the COVID-19 pandemic, women have increasingly obtained mifepristone through telehealth appointments, avoiding in-person doctor visits, a shift solidified by the Biden administration’s 2023 rules that eliminated the requirement for in-person pickup.
This shift is critical as many conservative states, including Louisiana, have imposed severe abortion restrictions or outright bans. Medication abortions now account for more than 60% of all abortions nationwide according to data from the Guttmacher Institute.
However, Louisiana sued to block the Biden-era rule, arguing it undermines its abortion restrictions. In a recent ruling, a federal district court declined to suspend access until the FDA could complete a safety review. Notably, analyses confirm that mifepristone is overwhelmingly safe, with fewer reported side effects than many common medications such as Viagra or penicillin.
Why This Matters Right Now
The 5th Circuit’s move to reinstate in-person pickup is already disrupting clinics, pharmacies, and patients, threatening to delay or block access to abortion pills precisely when time is critical. Restrictions come amid a nationwide surge in medication abortions after traditional surgical clinics closed due to new state bans.
The appeal highlights the chaos unfolding as patients scramble to understand new rules, risking their health and autonomy. A Supreme Court decision to pause the 5th Circuit’s order could stave off immediate barriers to care nationwide, including in South Carolina where abortion access remains heavily restricted and medication abortion is one of the few remaining legal options.
What’s Next: Supreme Court Considers Fast-Track Appeal
The Supreme Court has yet to rule on the emergency stay request, but the accelerated nature of the filing signals the issue is likely to return to the high court swiftly. A ruling could come days or weeks from now, shaping the future of abortion pill access across the US amid deepening legal battles.
For patients and providers, the stakes are high. The appeal urges the Court to maintain the Biden administration’s telehealth-friendly policies until a final decision, preserving access to safe, FDA-approved medication abortions and preventing a patchwork of state barriers that could worsen disparities in reproductive health care.
The SC Journal will continue tracking this developing story with urgent updates as the Supreme Court weighs a decision that could impact millions of Americans today.
